Anna Vilalta Lacarra

Dr. Anna Vilalta Lacarra serves as a Clinical Associate Professor at the Faculty of Medicine of the University of Navarra and specializes in Medical Oncology at the University Clinic of Navarra Cancer Center in Pamplona, focusing on lung cancer treatment and early-stage therapy development.

Her academic background includes:

• Graduation in Medicine from the University of Barcelona (2016)
• Medical Oncology Specialization at University of Navarra Clinic (2022)
• Master's Degree in Molecular Oncology from Rey Juan Carlos University (2019/2020)
• Immuno-Oncology Specialized Degree (2022/2023)
• PhD candidate in Applied Medicine and Biomedicine at University of Navarra

Her research centers on lung cancer translational studies with emphasis on clinical trial participation (over 100 trials as investigator/sub-investigator) and molecular mechanisms. Key focus areas include:

• Early-stage therapeutic development
• Thoracic tumor biology
• Immuno-oncology applications
• Molecular targeting strategies
• Translational biomarker research
• Clinical trial design for rare tumors

Professional recognition includes:

• SEOM We Are the Future Scholarship (2023)
• RCUN Research Award Best Oral Presentation (2022)
• Oncology Debate Forum Rare Tumors Competition First Prize (2019)

She contributes to academic training as teaching assistant for the Onco-Hematology Nursing Master's program and secures competitive funding for lung cancer translational projects. Her institutional involvement spans the Thoracic Tumors Department and Clinical Trials Unit, with active membership in the Spanish and European Societies of Medical Oncology.